GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (TSE:4694) » Definitions » Cyclically Adjusted Revenue per Share

BML (TSE:4694) Cyclically Adjusted Revenue per Share : 円3,322.09 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is BML Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BML's adjusted revenue per share for the three months ended in Dec. 2023 was 円900.062. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円3,322.09 for the trailing ten years ended in Dec. 2023.

During the past 12 months, BML's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of BML was 8.00% per year. The lowest was 4.40% per year. And the median was 6.40% per year.

As of today (2024-06-18), BML's current stock price is 円2835.00. BML's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円3,322.09. BML's Cyclically Adjusted PS Ratio of today is 0.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BML was 1.80. The lowest was 0.82. And the median was 1.19.


BML Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for BML's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Cyclically Adjusted Revenue per Share Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,523.05 2,653.69 2,917.53 3,175.89 -

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,175.89 3,224.85 3,279.94 3,322.09 -

Competitive Comparison of BML's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, BML's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BML's Cyclically Adjusted PS Ratio falls into.



BML Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BML's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=900.062/106.8000*106.8000
=900.062

Current CPI (Dec. 2023) = 106.8000.

BML Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 555.506 95.700 619.938
201406 626.685 98.000 682.959
201409 616.495 98.500 668.443
201412 623.935 97.900 680.656
201503 583.451 97.900 636.492
201506 645.580 98.400 700.690
201509 636.216 98.500 689.826
201512 656.171 98.100 714.364
201603 620.205 97.900 676.587
201606 668.161 98.100 727.417
201609 658.347 98.000 717.464
201612 663.296 98.400 719.919
201703 620.144 98.100 675.141
201706 680.904 98.500 738.280
201709 677.543 98.800 732.405
201712 674.842 99.400 725.082
201803 628.735 99.200 676.904
201806 701.266 99.200 754.992
201809 677.364 99.900 724.149
201812 710.839 99.700 761.460
201903 656.881 99.700 703.660
201906 723.257 99.800 773.986
201909 728.262 100.100 777.007
201912 725.005 100.500 770.453
202003 683.110 100.300 727.379
202006 642.715 99.900 687.107
202009 828.477 99.900 885.699
202012 945.056 99.300 1,016.435
202103 990.290 99.900 1,058.688
202106 1,157.620 99.500 1,242.551
202109 1,194.769 100.100 1,274.739
202112 1,010.995 100.100 1,078.664
202203 1,228.795 101.100 1,298.074
202206 1,021.115 101.800 1,071.268
202209 1,098.955 103.100 1,138.394
202212 1,022.939 104.100 1,049.471
202303 906.255 104.400 927.088
202306 904.967 105.200 918.731
202309 893.211 106.200 898.257
202312 900.062 106.800 900.062

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


BML  (TSE:4694) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BML's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2835.00/3322.09
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of BML was 1.80. The lowest was 0.82. And the median was 1.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BML Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of BML's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BML (TSE:4694) Business Description

Industry
Traded in Other Exchanges
N/A
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.

BML (TSE:4694) Headlines

No Headlines